The phrase "accurate survival" is correct and usable in written English.
It can be used in contexts discussing the precision or reliability of survival strategies, methods, or data.
Example: "The researchers focused on accurate survival rates of the species in various habitats to understand their adaptability."
Alternatives: "precise survival" or "reliable survival".
Only a third know accurate survival rates.
Accurate survival stratification in early-stage non-small cell lung cancer (NSCLC) could inform the use of adjuvant therapy.
Background: In order to ensure accurate survival estimates, population-based cancer registries must ascertain all, or nearly all, patients diagnosed with cancer in their catchment area, and obtain complete follow-up information on all deaths that occurred among registered cancer patients.
A birth cohort will also provide accurate survival data and information on causes of morbidity and mortality in early childhood.
Evaluation in a five-patient test set yielded an accurate survival estimate in two patients, but this method has not yet been internally or externally validated.
By analyzing each histologically distinct tumor, more accurate survival data have been generated.
Additionally, pet owners would benefit greatly from a more accurate projected survival time when weighing their dog's quality of life and their own monetary obligations in treatment decisions.
Such traits would provide additional information on the genetic potential to survive and generate more accurate EBVs for survival that can differentiate full-sibs.
Modern molecular and genomic profiling of cancer allows for a far more accurate prediction of survival.
This present strategy to assess morphological and clinical characteristics may be a more accurate indicator of survival rate and potentially an efficient indicator of new therapeutic alternatives.
The accurate prediction of survival probability for elasmobranchs subjected to prolonged immobilisation and diminished oxygen availability during capture and a vulnerable state post-release, is reliant on selecting a reliable set of biomarkers to profile as well as using them to design pre-release interventions which minimise elasmobranch death.
